Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep;38(9):934-941.
doi: 10.15537/smj.2017.9.20841.

Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor

Maizatul A Othman  1 , Wan Syamimee W Ghazali, Wan Zuraida W A Hamid, Kah K Wong, Nurul K Yahya
Affiliations

Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor

Maizatul A Othman et al. Saudi Med J. 2017 Sep.

Abstract

To evaluate levels of anti-carbamylated protein (anti-CarP) antibodies in rheumatoid arthritis (RA) patients and to determine their association with serological parameters and disease activity. Methods: A cross-sectional study involving 105 multiethnic RA patients (48 rheumatoid factor [RF]-positive and 57 RF-negative patients) was conducted at Hospital Universiti Sains Malaysia, Kelantan, Malaysia, from January 2015 to February 2016. Fifty healthy controls (HCs) were included. C-reactive protein (CRP), RF, anti-cyclic citrullinated peptide (anti-CCP) and anti-CarP antibodies were measured. A health assessment questionnaire (HAQ) was administered to the study participants and 28-joint Disease Activity Score (DAS28) were obtained. Results: The level of anti-CarP antibodies was significantly increased in the RA patients compared with HCs (p=0.042). The presence of anti-CarP antibodies was significantly associated with RF (p=0.019) and the HAQ (p=0.010). A significant association between the presence of anti-CarP antibodies and the DAS28 was not found (p=0.632). Conclusion: Our study provides further evidence that the level of anti-CarP antibodies is significantly elevated in RA patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The levels (OD 450nm) of anti-CCP antibodies A) and anti-CarP antibodies B) in RA patients and healthy controls, RA - rheumatoid arthritis.
Figure 2
Figure 2
The levels of anti-CarP and anti-CCP antibodies in 105 RA patients, (r=0.065; p=0.509), nti-Carp - Antibodies to carbamylated proteins, Anti-CCp - anti-cyclic citrullinated peptide
See this image and copyright information in PMC

References

    1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094–108. - PubMed
    1. Verheul M, Fearon U, Trouw L, Veale D. Biomarkers for rheumatoid and psoriatic arthritis. Clin Immunol. 2015;161:2–10. - PubMed
    1. Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, et al. The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73:1316–1322. - PubMed
    1. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–2581. - PubMed
    1. Jaskowski TD, Hill HR, Russo KL, Lakos G, Szekanecz Z, Teodorescu M. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies. J Rheumatol. 2010;37:1582–1588. - PubMed